Related Blog Posts
5 Steps to Restoring Trust in the Pharmaceutical Industry
9 hours ago ago from Pharma Reform
Like developing a tactical plan without a strategy is not advisable, before we get to specific actions, it is critical to understand the basis for reestablishing trust. First, completely restoring trust may not always be possible but that doesn’t mean you shouldn’t try. Without reestablishing trust, the pharmaceutical industry will find the evolving healthcare market even more challenging as it disregards the industry as a credible source ...
Related contentA Medical Doctor’s Open Letter Opposing the McCain Sponsored Dietary Supplement Safety Act (DSSA)
7 hours ago ago from Citizens For Health
Dear Senator McCain: Though I am a resident of New York, not Arizona, I suggest that someone in your staff reads my letter very carefully as I believe you are unwittingly sponsoring a bill with potentially onerous consequences, one that might if I read the information about it properly, lead to the death of hundreds of my patients fighting advanced, terminal cancer. I do not think, if I am correct in my interpretation, that you would ...
Related contentPharmaceutical Ingredient Outsourcing And GMP Consulting
6 hours ago ago from The Health Doctors Daily Blog
In the past decade, many pharmaceutical companies have outsourced ingredient production to Asian countries including China and India in the hope of lowering production costs and increasing profits. GMP consultants have however recently announced that more ingredient manufacturing is returning to the US. This article will discuss some of the reasons behind the shift back to US production bases. When pharmaceutical companies decided to ...
Related contentPolymorphism in Pharmaceutical Solids, Second Edition
22 minutes ago ago from Technology Contents
Product Description Using clear and practical examples, Polymorphism of Pharmaceutical Solids, Second Edition presents a comprehensive examination of polymorphic behavior in pharmaceutical development that is ideal for pharmaceutical development scientists and graduate students in pharmaceutical science. Fully updated and expanded, this new edition focuses on pharmaceutical aspects of polymorphism and solvatomorphism, while systematically ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
